Doseology Sciences, Inc. (DOSEF)
0.6746
0.00 (0.00%)
USD |
OTCM |
Apr 02, 16:00
Doseology Sciences EPS Diluted (Quarterly) : -0.0304 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -0.0746 |
| Achieve Life Sciences, Inc. | -0.2752 |
| Oncolytics Biotech, Inc. | -0.0139 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Edesa Biotech, Inc. | -0.2819 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.2433M |
| Revenue (Quarterly) | 0.0353M |
| Total Expenses (Quarterly) | 0.2786M |
| Enterprise Value | 4.922M |
| Gross Profit Margin (Quarterly) | -241.1% |
| Profit Margin (Quarterly) | -689.2% |
| Earnings Yield | -13.89% |
| Normalized Earnings Yield | -13.89 |